BMGL
BMGL
NASDAQ · Health Care

Basel Medical Group Ltd

$6.77
-0.03 (-0.44%)
Financial Highlights (FY 2026)
Revenue
943.4K
Net Income
-886,374
Gross Margin
Profit Margin
-94.0%
Rev Growth
+2.0%
D/E Ratio
0.93
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 38.9% 38.9%
Operating Margin -88.8% -79.9% 11.9% 13.4%
Profit Margin -94.0% -89.3% 11.7% 11.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 943.4K 924.6K 6.80M 6.40M
Gross Profit 2.64M 2.49M
Operating Income -837,513 -738,764 808.2K 856.0K
Net Income -886,374 -781,864 795.8K 756.4K
Gross Margin 38.9% 38.9%
Operating Margin -88.8% -79.9% 11.9% 13.4%
Profit Margin -94.0% -89.3% 11.7% 11.8%
Rev Growth +2.0% +2.0% -8.5% +14.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.60M 2.60M 4.33M 4.62M
Total Equity 2.78M 2.78M 8.88M 9.45M
D/E Ratio 0.93 0.93 0.49 0.49
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -739,063 -688,140 1.21M 1.15M
Free Cash Flow 635.1K 614.1K